LFST
LifeStance Health Group, Inc.
NASDAQ · USHealthcareMedical - Care Facilities
$11.34-2.07%
Price as of Jul 20, 2026
LFST financials
LifeStance Health Group, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $1.4B | $1.3B | $1.1B | $859.5M |
| Cost of revenue | $963.2M | $848.6M | $753.6M | $622.5M |
| Gross profit | $461.1M | $402.4M | $302.1M | $237.0M |
| Operating expenses | $437.0M | $434.0M | $491.2M | $447.2M |
| Operating income | $24.1M | -$31.6M | -$189.1M | -$210.2M |
| Net income | $9.7M | -$57.4M | -$186.3M | -$215.6M |
| EBITDA | $78.8M | $39.9M | -$104.9M | -$143.6M |
| Basic EPS | $0.03 | $-0.15 | $-0.51 | $-0.61 |
| Diluted EPS | $0.02 | $-0.15 | $-0.51 | $-0.61 |
| Balance sheet | ||||
| Cash & equivalents | $248.6M | $154.6M | $78.8M | $108.6M |
| Total assets | $2.2B | $2.1B | $2.1B | $2.2B |
| Total liabilities | $682.9M | $672.0M | $681.0M | $655.1M |
| Stockholders’ equity | $1.5B | $1.4B | $1.4B | $1.5B |
| Total debt | $194.1M | $485.2M | $511.0M | $478.8M |
| Net debt | -$54.5M | $330.6M | $432.2M | $370.2M |
| Cash flow | ||||
| Operating cash flow | $146.2M | $107.3M | -$16.9M | $52.8M |
| Capital expenditure | -$36.1M | -$21.6M | -$40.5M | -$79.3M |
| Free cash flow | $110.0M | $85.7M | -$57.4M | -$26.5M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | -$904.0K |